ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers

NCT ID: NCT04367857

Last Updated: 2025-04-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-18

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The novel coronavirus (SARS-CoV-2) has spread all around the world and testing has posed a challenge globally. Health care providers are highly exposed and are an important group to test. On top of these concerns, health care workers are also stressed by the needs on responders in the COVID-19 crisis. The investigators will look at different ways to measure how common COVID-19 is among health care workers, how common is the presence of antibodies by serological tests (also known as serostatus). The investigators will describe health worker mental and emotional well-being and their coping strategies in their institutional settings. Lastly, the investigators will describe how knowing serostatus can affect individuals' mental and emotional well-being and how to cope in the midst of the COVID-19 response. This will help to how to better test and help healthcare workers in the COVID-19 pandemic and prepare for possible future outbreaks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The rapid spread of the novel coronavirus SARS-CoV-2 has resulted in pandemic levels and a global challenge in diagnosing infection. Diagnosing infection, defining recovery and immunity has been challenging. Health care providers in particular are very interested in knowing their status as they are highly exposed, and if infectious, can potentially transmit infection nosocomially (in the healthcare workplace setting) and to their household. In addition to understanding their exposure risk, infectious period, and immunity status, health care workers are reporting high levels of psychosocial distress including anxiety and burnout. The investigators aim to assess the baseline and cumulative seroprevalence of SARS-CoV-2 among health care workers using both quantitative and qualitative serological assays; describe psychosocial well-being and coping strategies among health workers in their institutional settings and describe how knowledge of one's serostatus affect psychosocial well-being, and coping strategies. Findings from this study will inform; 1) use of serological assays and testing algorithms, and 2) approaches to manage psychosocial stress for healthcare workers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid-19 Coronavirus Infection Coronavirus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prior Positive polymerase chain reaction (PCR) and Recovered

Prior Positive PCR result, fully recovered, back at work and symptom free for greater than or equal than 14 days.

COVID-19 Serology

Intervention Type OTHER

Quantitate Serology enzyme-linked immunosorbent assay (ELISA) for COVID-19

Health Care Worker Survey

Intervention Type BEHAVIORAL

The purpose of this survey is to assess how healthcare workers are experiencing and coping with the COVID-19 crisis.

Never tested, history of COVID-19 Symptoms and Recovered

Never tested and history of COVID-19 symptoms and symptom-free for more than 14 days

COVID-19 Serology

Intervention Type OTHER

Quantitate Serology enzyme-linked immunosorbent assay (ELISA) for COVID-19

Health Care Worker Survey

Intervention Type BEHAVIORAL

The purpose of this survey is to assess how healthcare workers are experiencing and coping with the COVID-19 crisis.

Never tested and current COVID-19 Symptoms

Never tested and current COVID-19 Symptoms (e.g. referred by a provider or clinic)

COVID-19 Serology

Intervention Type OTHER

Quantitate Serology enzyme-linked immunosorbent assay (ELISA) for COVID-19

Health Care Worker Survey

Intervention Type BEHAVIORAL

The purpose of this survey is to assess how healthcare workers are experiencing and coping with the COVID-19 crisis.

Never tested and asymptomatic

Never tested and asymptomatic for COVID-19 symptoms, including asymptomatic health care worker

COVID-19 Serology

Intervention Type OTHER

Quantitate Serology enzyme-linked immunosorbent assay (ELISA) for COVID-19

Health Care Worker Survey

Intervention Type BEHAVIORAL

The purpose of this survey is to assess how healthcare workers are experiencing and coping with the COVID-19 crisis.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

COVID-19 Serology

Quantitate Serology enzyme-linked immunosorbent assay (ELISA) for COVID-19

Intervention Type OTHER

Health Care Worker Survey

The purpose of this survey is to assess how healthcare workers are experiencing and coping with the COVID-19 crisis.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older
* NewYork-Presbyterian (NYP) healthcare personnel employee or affiliate
* Understands and reads English

Exclusion Criteria

* Younger than 18 years of age
* Mentally and/or physically unable to complete study requirements
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Columbia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Magdalena Sobieszczyk, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Columbia University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

NewYork-Presbyterian Hosptial/Columbia University Irving Medical Center

New York, New York, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Brett Gray

Role: CONTACT

212-305-1570

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Brett Gray

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AAAS9998

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

COVID-19 Serology and Immunosenescence
NCT04563650 ACTIVE_NOT_RECRUITING NA